| Product Code: ETC9955670 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Stroke Diagnostics Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Stroke Diagnostics Market - Industry Life Cycle |
3.4 United Kingdom (UK) Stroke Diagnostics Market - Porter's Five Forces |
3.5 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume Share, By Severity, 2021 & 2031F |
3.6 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume Share, By Stage, 2021 & 2031F |
4 United Kingdom (UK) Stroke Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of strokes in the UK |
4.2.2 Technological advancements in diagnostic tools and techniques |
4.2.3 Growing awareness about the importance of early diagnosis and treatment of strokes |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of diagnostic devices |
4.3.2 High cost associated with advanced diagnostic tools |
4.3.3 Limited accessibility to diagnostic facilities in rural areas of the UK |
5 United Kingdom (UK) Stroke Diagnostics Market Trends |
6 United Kingdom (UK) Stroke Diagnostics Market, By Types |
6.1 United Kingdom (UK) Stroke Diagnostics Market, By Severity |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume, By Severity, 2021- 2031F |
6.1.3 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume, By Moderate, 2021- 2031F |
6.1.4 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume, By Severe, 2021- 2031F |
6.1.5 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume, By Mild, 2021- 2031F |
6.2 United Kingdom (UK) Stroke Diagnostics Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume, By Computed TomographyCT Scan, 2021- 2031F |
6.2.3 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume, By Computed Tomography AngiographyCTA, 2021- 2031F |
6.2.4 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume, By Magnetic Resonance ImagingMRI, 2021- 2031F |
6.2.5 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume, By Magnetic Resonance AngiographyMRA, 2021- 2031F |
6.2.6 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume, By Transcranial Doppler Ultrasound, 2021- 2031F |
6.2.7 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume, By Video Head Impulse TestVHIT, 2021- 2031F |
6.3 United Kingdom (UK) Stroke Diagnostics Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume, By Ischemic Stroke, 2021- 2031F |
6.3.3 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume, By Hemorrhagic Stroke, 2021- 2031F |
6.3.4 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume, By Transient Ischemic AttacksTIAS, 2021- 2031F |
6.4 United Kingdom (UK) Stroke Diagnostics Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.4.5 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.5 United Kingdom (UK) Stroke Diagnostics Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.5.3 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume, By Third Party Distributors, 2021- 2031F |
6.5.4 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United Kingdom (UK) Stroke Diagnostics Market, By Stage |
6.6.1 Overview and Analysis |
6.6.2 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume, By Pre Operative, 2021- 2031F |
6.6.3 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume, By Peri Operative, 2021- 2031F |
6.6.4 United Kingdom (UK) Stroke Diagnostics Market Revenues & Volume, By Post Operative, 2021- 2031F |
7 United Kingdom (UK) Stroke Diagnostics Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Stroke Diagnostics Market Export to Major Countries |
7.2 United Kingdom (UK) Stroke Diagnostics Market Imports from Major Countries |
8 United Kingdom (UK) Stroke Diagnostics Market Key Performance Indicators |
8.1 Average time taken for stroke diagnosis and treatment |
8.2 Number of healthcare facilities offering stroke diagnostic services |
8.3 Percentage of population screened for stroke risk factors |
8.4 Adoption rate of new diagnostic technologies for strokes |
8.5 Patient satisfaction with diagnostic services provided |
9 United Kingdom (UK) Stroke Diagnostics Market - Opportunity Assessment |
9.1 United Kingdom (UK) Stroke Diagnostics Market Opportunity Assessment, By Severity, 2021 & 2031F |
9.2 United Kingdom (UK) Stroke Diagnostics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 United Kingdom (UK) Stroke Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 United Kingdom (UK) Stroke Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 United Kingdom (UK) Stroke Diagnostics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.6 United Kingdom (UK) Stroke Diagnostics Market Opportunity Assessment, By Stage, 2021 & 2031F |
10 United Kingdom (UK) Stroke Diagnostics Market - Competitive Landscape |
10.1 United Kingdom (UK) Stroke Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Stroke Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here